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Abstract 
Background: Laparoscopic hepatectomy is increasingly being used to treat hepatocellular carcinoma (HCC). How‑
ever, few studies have examined the treatment of recurrent HCC in patients who received a prior hepatectomy. The 
present prospective study compared the clinical efficacy of laparoscopic surgery with conventional open surgery in 
HCC patients with postoperative tumor recurrence.
Methods: We conducted a prospective study of 64 patients, all of whom had undergone open surgery once before, 
who were diagnosed with recurrent HCC between June 2014 and November 2014. The laparoscopic group (n = 31) 
underwent laparoscopic hepatectomy, and the control group (n = 33) underwent conventional open surgery. Opera‑
tion time, intraoperative blood loss, surgical margins, postoperative pain scores, postoperative time until the patient 
could walk, anal exsufflation time, length of hospital stay, and inpatient costs were compared between the two 
groups. The patients were followed up for 1 year after surgery, and relapse‑free survival was compared between the 
two groups.
Results: All surgeries were successfully completed. No conversion to open surgery occurred in the laparoscopic 
group, and no serious postoperative complications occurred in either group. No significant difference in inpatient 
costs was found between the laparoscopic group and the control group (P = 0.079), but significant differences 
between the two groups were observed for operation time (116.7 ± 37.5 vs. 148.2 ± 46.7 min, P = 0.031), intraopera‑
tive blood loss (117.5 ± 35.5 vs. 265.9 ± 70.3 mL, P = 0.012), postoperative time until the patient could walk (1.6 ± 0.6 
vs. 2.2 ± 0.8 days, P < 0.05), anal exsufflation time (2.1 ± 0.3 vs. 2.8 ± 0.7 days, P = 0.041), visual analogue scale pain 
score (P < 0.05), postoperative hepatic function (P < 0.05), and length of hospital stay (4.5 ± 1.3 vs. 6.0 ± 1.2 days, 
P = 0.014). During the 1‑year postoperative follow‑up period, 6 patients in each group had recurrent HCC on the 
side of the initial operation, but no significant difference between groups was observed in the recurrence rate or 
relapse‑free survival. In the laparoscopic group, operation time, postoperative time until the patient could walk, anal 
exsufflation time, and inpatient costs were not different (P > 0.05) between the patients with contralateral HCC recur‑
rence (n = 18) and those with ipsilateral HCC recurrence (n = 13). However, intraoperative blood loss was signifi‑
cantly less (97.7 ± 14.0 vs. 186.3 ± 125.6 mL, P = 0.012) and the hospital stay was significantly shorter (4.2 ± 0.7 vs. 
6.1 ± 1.7 days, P = 0.021) for the patients with contralateral recurrence than for those with ipsilateral recurrence.
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Background
Liver cancer is a common cancer in China, particularly 
in men and residents of rural areas [1, 2]. Postoperative 
recurrent hepatocellular carcinoma (HCC) presents a 
challenge for surgeons. Currently, radiofrequency abla-
tion is an effective treatment for HCCs that are smaller 
than 3  cm [3–6]; transcatheter arterial chemoemboliza-
tion (TACE) combined with computed tomography-
guided percutaneous thermal ablation can also be used 
to treat these tumors [7]. However, in most cases, radi-
ofrequency ablation is contraindicated in patients with 
recurrent HCC because of large tumor size, severe peri-
toneal adhesions, or tumor location (at the surface of the 
liver and adjacent to large vessels). TACE is generally a 
non-radical treatment; repeat surgical resection is an 
effective radical treatment. In the past, open surgery was 
often performed, which had disadvantages such as a large 
incision, a complex surgical approach, and a slow recov-
ery. The development of laparoscopic techniques has 
produced advances in the complete laparoscopic resec-
tion of recurrent HCC [7–9], and single-entry laparo-
scopic resection and radiofrequency ablation combined 
with laparoscopic resection of recurrent HCC have been 
reported [10]. However, further research is needed to 
evaluate the treatment outcomes of these operations. We 
conducted a prospective study of 64 patients who under-
went resection of recurrent HCC at our hospital between 
June 2014 and November 2014 and performed a com-




The Institutional Review Board at Sun Yat-sen University 
Cancer Center approved this prospective study, and the 
methods were carried out in accordance with approved 
guidelines (ClinicalTrials.gov ID: NCT02613156).
The inclusion criteria were as follows: (1) recurrent 
HCC after open surgery; (2) recurrent HCC located in 
any part of the left lateral lobe or the diaphragm side of 
the right lobe and near the surface of the liver, without 
noteworthy surgical contraindications; (3) no major ves-
sel or bile duct tumor invasion or metastasis; (4) grade A 
or B liver function or grade C liver function that recov-
ered to grade A after liver-protective treatment; and (5) 
a signed informed consent form from the patient. The 
exclusion criteria were as follows: (1) major vessel or bile 
duct tumor invasion; (2) recurrent HCC located in the 
right liver parenchyma and near secondary vessels and 
bile ducts; (3) extrahepatic metastasis; (4) grade C liver 
function; (5) noteworthy surgical contraindications; or 
(6) patient refusal to undergo laparoscopic hepatectomy.
Observation indicators and detection methods
Routine biochemical tests were conducted as part of the 
postoperative re-examination, and changes in alanine 
aminotransferase and aspartate aminotransferase levels 
were used to assess postoperative liver function changes. 
The severity of adhesions was assessed using the modi-
fied American Fertility Society (mAFS) classification 
scoring system. Pain scores were evaluated using a visual 
analogue scale (VAS) after surgery (the 1st day). Patients 




The surgical instruments used for patients in the laparo-
scopic group included conventional laparoscopic instru-
ments (three 5-mm trocars, two 10-mm trocars, and two 
damage-free laparoscopic clamps), the STORZ high-res-
olution laparoscopic operating system (Mittelstraße, Tut-
tlingen, Germany), the GEN300 ultrasonic scalpel system 
(Johnson and Johnson, New Brunswick, NJ, USA), a lapa-
roscopic linear cutter stapler (Johnson and Johnson, New 
Brunswick, NJ, USA), a laparoscopic ultrasound device, 
LigaSure, bipolar coagulation, titanium laparoscopic 
clips, and absorbable hemostatic gauze.
The surgical instruments used for patients in the con-
trol group included conventional laparotomy instru-
ments, an electric scalpel, an intraoperative B-mode 
ultrasound device, proline tubing, gelatin sponges, and 
absorbable hemostatic gauze.
Surgical approaches
All patients received general anesthesia and intubation. 
Based on the tumor location, patients in the laparoscopic 
group were placed in the supine position, with their 
legs spread apart or horizontally; patients in the control 
group were positioned horizontally. Moreover, in the 
Conclusions: For the patients who previously underwent conventional open surgical resection of HCC, complete 
laparoscopic resection was safe and effective for recurrent HCC and resulted in a shorter operation time, less intraop‑
erative blood loss, and a faster postoperative recovery than conventional open surgery. Laparoscopic resection was 
especially advantageous for the patients with contralateral HCC recurrence.
Keywords: Laparoscopic hepatectomy, Hepatocellular carcinoma, Recurrence, Relapse‑free survival
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laparoscopic group, if the tumor was in the right lobe, a 
five-way-access approach was used, in which the surgeon 
stood on the same side as the tumor, the laparoscope-
supporting assistant stood between the patient’s legs, and 
the surgical assistant stood on the other side of the tumor. 
A small incision (1.5  cm in diameter) was made along 
the upper navel edge, and a Veress needle was inserted 
to establish pneumoperitoneum. Next, a 10-mm trocar 
was inserted, and then the laparoscope was inserted to 
explore the liver tumor and peritoneal adhesions. Pres-
sure was maintained at 8–12 mmHg. Next, a small inci-
sion (0.5 cm in diameter) was made 2 cm underneath the 
right costal margin, and a 5-mm trocar was inserted for 
auxiliary surgical access. Another small incision (1.0 cm 
in diameter) was made laterally and inferiorly, and a 
10-mm trocar was inserted and used as the main surgi-
cal access. A small incision (0.5 cm in diameter) was then 
made underneath the left costal margin, and a 5-mm 
trocar was inserted for auxiliary surgical access. These 
access points were located as far away from the adhesions 
as possible. If it was impossible to circumvent peritoneal 
adhesions, laparoscopic separation of the adhesions was 
performed first. If the tumor was in the S2 or S3 segment, 
a four-way-access approach was used: the surgeon stood 
on the right side of the patient, and the first assistant 
stood on the left side of the patient. Only one access point 
underneath the left costal margin was required. During 
resection of tumor lesions and liver segments from the 
right lobe, the surgeon separated adhesions in the oper-
ating field that were near the abdominal wall using an 
ultrasonic scalpel and then determined the location and 
incision edges of the tumor under the guidance of laparo-
scopic ultrasound. Next, the surgeon used an ultrasound-
guided scalpel to separate the liver parenchyma, followed 
by the use of LigaSure coagulation to stop bleeding from 
small vessels. Groups of titanium clips were used to stop 
the bleeding if the LigaSure coagulation was ineffective. 
The surgeon resected the tumor after separating the liver 
parenchyma. If the tumor was in the S2 or S3 segment, 
the surgeon performed laparoscopic resection of the left 
lateral lobe. After separating the adhesions, the surgeon 
cut the left coronary ligament and the left triangular liga-
ment. The assistant pulled the left lobe upward and to 
the right, and the surgeon separated the hepatogastric 
ligament and verified that the incision edge was more 
than 2 cm away from the tumor (guided by laparoscopic 
ultrasound). Next, the surgeon separated the liver paren-
chyma along the incisions on the surface of the liver until 
reaching the vascular pedicle of the S2 and S3 segments 
and then used a laparoscopic linear cutter stapler to cut 
the residual liver tissue and vessels to resect the left lobe. 
A gelatin sponge was used to stop minor bleeding in the 
operating field. After the wound was checked for active 
bleeding, the surgeon expanded the incision at the navel 
edges to remove the specimen. Next, the surgeon placed 
an abdominal drainage tube according to standard proce-
dures. For patients in the control group, if the tumor was 
in the left lateral lobe or the right anterior lobe, an inci-
sion was made along the midline of the abdominal wall; if 
the tumor was in the right lobe, an oblique incision was 
made underneath and along the costal margin. Adhesions 
were separated after the abdominal wall was opened, and 
intraoperative B-mode ultrasound was used to determine 
the location of the tumor and incision lines. A conven-
tional surgical approach was used for local resection or 
segmental resection of the HCC. If the tumor was in the 
S2 or S3 segment, the left lateral lobe was resected with 
an open lobectomy, and an abdominal drainage tube was 
placed according to standard procedures.
Statistical analysis
SPSS 21.0 software was used to process all data. Meas-
urement data are expressed as the mean  ±  standard 
deviation and were analyzed with an independent-sample 
t test. Count data were analyzed with the χ2 test. Relapse-
free survival was analyzed using the Kaplan–Meier 
method. P < 0.05 were considered statistically significant.
Results
Study population and baseline clinical characteristics
We studied 64 patients who underwent resection of 
recurrent HCC at our hospital between June 2014 and 
November 2014. The laparoscopic group comprised 31 
patients who underwent laparoscopic resection of the 
recurrent HCC; the control group comprised 33 patients 
who underwent conventional open surgery. Case group-
ing was decided by a multidisciplinary team. In the lapa-
roscopic group, 26 patients were men and 5 patients were 
women (age range, 37–66  years; median, 54  years); the 
recurrent tumors had an average size of 2.5 ± 1.0 cm. In 
the control group, 27 patients were men and 6 patients 
were women (age range, 34–65 years; median, 59.5 years); 
the recurrent tumors had an average size of 3.8 ± 1.1 cm. 
The hepatic falciform ligament comprised the border 
between the left lateral lobe (to the left) and the right lobe 
(to the right). Detailed clinical data of the two groups of 
patients are shown in Table  1. No significant difference 
was observed between the two groups of patients in their 
general information before the operation.
There were 53 men and 11 women patients, with a 
median age of 52.5  years (range, 45–74  years). Except 
for hepatectomy, 9, 5, and 2 patients underwent further 
TACE, local thermal ablation, and sorafenib treatment, 
respectively, before this study. The mean baseline char-
acteristics were similar between the two groups. The 
median follow-up period for all patients was 17 months 
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(range, 12–18  months); the median survival time was 
11.0 months (95% confidence interval 9.2–15.9 months).
Efficacy of complete laparoscopic resection
All operations were successfully completed, and none of 
the patients in the laparoscopic group required conver-
sion to open surgery. Moreover, no serious postoperative 
complications were observed in either group. Signifi-
cant differences were observed between the laparoscopic 
and control groups in operation time (116.7  ±  37.5 vs. 
148.2 ±  46.7  min, P =  0.031), intraoperative blood loss 
(117.5  ±  35.5 vs. 265.9  ±  70.3  mL, P  =  0.012), post-
operative time until the patient could walk (1.6  ±  0.6 
vs. 2.2  ±  0.8  days, P  =  0.004), anal exsufflation time 
(2.1  ±  0.3 vs. 2.8  ±  0.7  days, P  =  0.041), VAS scores 
(P  <  0.001), postoperative hepatic function (P  <  0.05), 
and length of hospital stay (4.5 ± 1.3 vs. 6.0 ± 1.2 days, 
P =  0.014). In contrast, no differences between the two 
groups were observed in surgical margins, grade of peri-
toneal adhesions, or inpatient costs (Table 2).
Comparison of patients with contralateral and ipsilateral 
recurrence after laparoscopic hepatectomy
Moreover, we compared the data for patients in the lapa-
roscopic group with contralateral or ipsilateral recur-
rence (18 and 13 patients, respectively, based on the 
initial operation). Interestingly, compared with patients 
with ipsilateral recurrence, patients with contralateral 
recurrence tended to have less intraoperative blood 
loss (97.7 ±  14.0 vs. 186.3 ±  125.6  mL, P =  0.012) and 
a shorter hospital stay (4.2  ±  0.7 vs. 6.1  ±  1.7  days, 
P = 0.021) (Table 3).
Table 1 Baseline characteristics of all enrolled patients
BMI body mass index, ALT alanine aminotransferase, AST aspartate aminotransferase, AFP α-fetoprotein, HBV hepatitis B virus
Characteristic Laparoscopic  
group




 Men 26 27
 Women 5 6
Age (years) 0.413
 Median 54 59.5
 Range 37–66 34–65
BMI 0.912
 Median 24.4 25.0
 Range 19.1–31.0 21.8–29.9
Initial surgical lesion site (cases) 0.665
 Right lobe 22 25
 Left lobe 9 8
Primary tumor size (cm) 4.1 ± 1.5 4.9 ± 2.6 0.382
Time to recurrence (months) 28.4 ± 27.7 27.5 ± 16.3 0.282
Size of recurrent tumor (cm) 2.5 ± 1.0 3.8 ± 1.1 0.45
Recurrent site (cases) 0.632
 Right lobe 16 19
 Left lobe 15 14
Operation method (cases) 0.955
 Left lateral lobectomy 12 13
 Local resection 19 20
Total bilirubin (μmol/L) 31.2 ± 7.4 33.7 ± 10.4 0.742
Albumin (g/L) 35.2 ± 3.3 36.4 ± 4.3 0.532
ALT (U/L) 49.6 ± 6.4 76.3 ± 7.5 0.671
AST (U/L) 52.4 ± 7.4 69.4 ± 8.4 0.832
Prothrombin time (s) 11.5 ± 0.7 12.4 ± 1.0 0.651
AFP (cases) 0.264
 >400 ng/mL 27 24
 <400 ng/mL 4 9
HBV‑DNA (log10 IU/mL) 3.50 ± 0.8 3.0 ± 0.2 0.192
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Short‑term effect of laparoscopic hepatectomy 
on recurrent HCC
During the 1-year postoperative follow-up period, 5 
patients (16.1%) in the laparoscopic group and 7 patients 
(21.2%) in the control group relapsed, although no sig-
nificant difference was observed in relapse-free survival 
between the two groups (Fig. 1).
Discussion
Based on the results of this study, we propose that laparo-
scopic resection of recurrent HCC is feasible for patients 
who previously underwent conventional open surgery. 
Compared with conventional open surgery, complete lap-
aroscopic resection of recurrent HCC has the advantages 
of a shorter operation time, less intraoperative blood loss, 
and less pain, resulting in a faster postoperative recovery 
and a shorter hospital stay.
Since Reich et al. [11] reported the first successful lapa-
roscopic liver resection in 1991, the use of laparoscopy 
for liver resection has gradually increased. Additionally, 
laparoscopic liver surgery has become increasingly com-
mon as laparoscopic surgical instruments have improved 
and surgeons have gained more experience [12–16]. Sev-
eral studies have reported laparoscopic resection of the 
caudate lobe and complete laparoscopic resection com-
bined with associated liver partition and portal vein liga-
tion for staged hepatectomy (ALPPS) [17–20]. Moreover, 
pilot studies have confirmed the feasibility and value of 
complete laparoscopic ALPPS, and ALPPS has been 
used to remove donor livers during liver transplantation 
[21–24].
Generally, because of the complexity of postoperative 
adhesion, laparoscopic surgery is not recommended for 
repeat surgery, and there have been only a few reports 
on this approach. Kanazawa et al. [8] and Chan et al. [9] 
reported their results for laparoscopic resection of recur-
rent HCC; they found that patients in the laparoscopic 
group had significantly less intraoperative blood loss than 
patients in the open surgery group, which was consist-
ent with the results of our study. In addition, we found 
that, regarding operation time, postoperative time until 
the patient could walk, postoperative pain, and length 
of hospital stay, laparoscopic resection was superior to 
open surgery. Patients in the laparoscopic group had a 
shorter operation time for the following reasons: (1) once 
pneumoperitoneum was established under laparoscopic 
guidance, the increase in pressure increased the tension 
Table 2 Comparison of  perioperative conditions 
between the laparoscopic and control groups
VAS visual analogue scale, BMI body mass index, ALT alanine aminotransferase, 
AST aspartate aminotransferase, AFP α-fetoprotein, HBV hepatitis B virus






Operation time (min) 116.7 ± 37.5 148.2 ± 46.7 0.031
Surgical margin (cm) 2.1 ± 1.2 2.2 ± 0.6 0.068
Intraoperative blood loss 
(mL)
117.5 ± 35.5 265.9 ± 70.3 0.012
Grade of peritoneal adhe‑
sions (cases)
0.880
 1 18 20
 2 8 6
 3 3 4
 4 2 3
VAS score (cases) <0.001
 0–3 20 9
 4–6 8 18
 7–10 3 6
ALT (U/L)a 179.6 ± 17.4 312.3 ± 28.2 0.012
AST (U/L)a 84.1 ± 16.1 223.4 ± 30.1 0.029
Anal exsufflation time (days) 2.1 ± 0.3 2.8 ± 0.7 0.041
Postoperative time until the 
patient could walk (days)
1.6 ± 0.6 2.2 ± 0.8 0.004
Hospital stay (days) 4.5 ± 1.3 6.0 ± 1.2 0.014
Inpatient costs (×10,000 
yuan)
6.3 ± 0.4 5.5 ± 0.6 0.079
Postoperative recurrence 
[cases (%)]
5 (16.1) 7 (21.2) 0.603
Table 3 Comparison of patients with contralateral and ipsilateral recurrence after laparoscopic hepatectomy





Recurrent tumor size (cm) 4.4 ± 0.9 3.7 ± 1.4 0.227 1.3
Operation time (min) 112.4 ± 18.6 159.4 ± 39.0 0.034 −0.6
Surgical margin (cm) 3.6 ± 1.0 2.1 ± 0.6 0.166 −0.3
Intraoperative blood loss (mL) 97.7 ± 14.0 186.3 ± 125.6 0.012 −2.1
Postoperative time until the patient could walk (days) 1.8 ± 0.5 1.6 ± 0.5 0.478 −0.5
Anal exsufflation time (days) 2.3 ± 0.5 2.1 ± 0.7 0.634 −0.2
Hospital stay (days) 4.2 ± 0.7 6.1 ± 1.7 0.021 −2.1
Inpatient costs (×10,000 yuan) 6.2 ± 0.3 5.8 ± 0.7 0.575 −0.6
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of adhesions, which, together with a large laparoscopic 
operating field, facilitated the separation of the adhe-
sions; (2) certain adhesions in non-operating fields could 
be circumvented by laparoscopic instruments and thus 
required no separation, resulting in no effect on expo-
sure or the operation; and (3) during resection of the left 
lateral lobe, a cutting and closure device was typically 
used, eliminating the need to separate segmental vessels, 
thereby greatly reducing the operation time and bleeding. 
Moreover, the pressure of the pneumoperitoneum itself 
played a role in hemostasis. Intestinal adhesions were 
observed in both the laparoscopic group and the control 
group. The adhesions were rated as 4 or lower (according 
to the mAFS scoring system), and no extremely severe 
adhesions (5 or higher) were observed in this study, 
which highlighted the advantages of using a laparoscope, 
aided by large operating fields and the pressure produced 
by pneumoperitoneum, to separate mild to moderate 
adhesions. Patients who underwent laparoscopic resec-
tion of recurrent HCC had significantly lower postopera-
tive pain scores, mainly because of markedly less nerve 
damage to the abdominal wall due to the use of smaller 
access points than those used for conventional large inci-
sions. Moreover, because laparoscopic resection caused 
fewer injuries than open surgery, the patients could 
walk sooner, and their bowel functions recovered faster 
after the operation, thereby shortening the hospital stay. 
Nevertheless, no significant difference in inpatient costs 
was observed between the two groups.
During the 1-year follow-up period, no patients in either 
group died. Six patients in each group had recurrent HCC 
on the same side as the initial operation and underwent 
interventional treatment or radiofrequency ablation. No 
significant difference was observed in relapse-free sur-
vival between the two groups. A subgroup analysis of 
patients who underwent laparoscopic resection showed 
that intraoperative blood loss was significantly less and 
the hospital stay was significantly shorter for patients who 
had contralateral recurrence than for patients who had 
ipsilateral recurrence. For patients who had contralateral 
recurrence, milder adhesions in the operating field helped 
to reduce bleeding during the separation of peritoneal 
adhesions, thereby shortening the operation time, acceler-
ating postoperative recovery, and highlighting the advan-
tages of laparoscopic resection.
Conclusions
We found that laparoscopic resection of HCC is more 
effective than open surgery, and we recommend that 
it may be more widely used in clinical practice, even in 
cases of recurrent HCC. Complete laparoscopic resection 
is especially advantageous for recurrent lesions near the 
surface of the liver, such as the edges of the contralateral 
lobe, left lobe, and right lobe, and may be used as the pre-
ferred treatment. However, this was a non-randomized 
study, and a randomized controlled study with a large 
sample size is needed to confirm our results.
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